Table 3 Multivariate analysis of OS and DFS in the TNBC patients treated with chemotherapy
Variables | OS | DFS | ||||||
|---|---|---|---|---|---|---|---|---|
No. | HR | 95% CI | P value | No. | HR | 95% CI | P value | |
NR1D1 expression | ||||||||
Low | 122 | 1.00 | 123 | 1.00 | ||||
High | 37 | 0.09 | 0.01–0.65 | 0.017 | 37 | 0.16 | 0.04–0.68 | 0.013 |
Tumor size | ||||||||
T1 | 55 | 1.00 | 56 | 1.00 | ||||
T2 | 93 | 0.76 | 0.14–4.13 | 0.753 | 93 | 0.73 | 0.14–3.79 | 0.705 |
T3 or T4 | 11 | 1.05 | 0.15–7.37 | 0.963 | 11 | 0.76 | 0.10–5.65 | 0.793 |
LN metastasis | ||||||||
No | 93 | 1.00 | 94 | 1.00 | ||||
Yes | 66 | 0.97 | 0.27–3.57 | 0.967 | 66 | 0.64 | 0.19–2.19 | 0.474 |
AJCC stage | ||||||||
I | 42 | 1.00 | 43 | 1.00 | ||||
II | 84 | 2.36 | 0.30–18.35 | 0.413 | 84 | 3.02 | 0.43–21.03 | 0.265 |
III | 33 | 8.61 | 0.52–144.06 | 0.134 | 33 | 10.53 | 0.71–157.21 | 0.088 |